Articles

Honeywell’s project team has remotely and efficiently migrated Richter Gedeon’s process control system with limited onsite staffing and resources.

Honeywell Completes Remote Control System Migration for Hungarian Pharma Manufacturer

A novel PTA technology captures more than 95% of the genomes of single cells, providing more uniform, accurate, and reproducible single-cell analysis data.

BioSkryb Discusses First Data Demonstrating Improved Accuracy in Single Cell Analyses

The collaboration addresses the need for risk mitigation plans in cell therapies.

Cytiva and 4Tune Engineering Collaborate on Cell Therapy Quality Risk Management

Set to be operational by the first quarter of 2022, the 140,000-ft2 facility will feature up to six 2000-L, single-use bioreactor systems along with additional harvest and purification equipment to produce up to 100 commercial batches annually. 

KBI Biopharma to Open $150 Million Commercial Manufacturing Facility in North Carolina

The gene therapy increases the ability of retina cells to make a soluble form of CD59, a protein that shields the retina from damage, to prevent additional damage and to preserve vision. 

Janssen Pharmaceuticals Announces Acquisition of Vision Care Gene Therapy

Janssen announces rolling submissions for its COVID-19 vaccine with Health Canada and EMA.

J&J Initiates COVID-19 Vaccine Approvals in Canada and Europe

Under the terms of the partnership, Colorcon will work to accelerate i2O’s research and development efforts.

Colorcon and i2O Therapeutics Partner for Liquid Technology Development 

CGT Catapult has launched the Advanced Therapies Skills Training Network, designed to open career opportunities and upskill staff in advanced therapy and vaccine manufacturing in the UK.

Nationwide Skills Development Program for Advanced Therapies Launches in UK

eTheRNA Immunotherapies has entered into a strategic cooperation and product license agreement with China Grand Pharmaceutical and Healthcare Holdings to form a new joint venture company, Nanjong AuroRNA Biotech.

Joint Venture Company Forms to Deploy eTheRNA’s Technology for R&D

The grant will support the advancement of glycoengineering technology for plant-derived proteins developed by a University of Alberta scientist partnered with PlantForm.

NSERC Awards Alliance Grant to PlantForm to Enable Commercial-Scale Production of Protein Therapeutics

The investment will expand and upgrade manufacturing capacity and technology for pre-fillable syringes and will also includes a new manufacturing facility in Europe. 

BD to Invest $1.2 Billion Over Four Years in Pre-Fillable Syringe Manufacturing Capacity 

MHRA has granted a temporary authorization for emergency use to Pfizer and BioNTech for the mRNA vaccine against COVID-19.

MHRA Grants Emergency Use Authorization for Pfizer and BioNTech’s COVID-19 Vaccine

The expansion will include new suites for the development and clinical manufacturing of drug product intermediates and drug products and cGMP suites for early-phase cGMP manufacture.

Lonza to Expand Particle Engineering and Drug Product Capabilities at its Oregon Site

Moderna has filed for authorization for its COVID-19 vaccine candidate, which has shown high efficacy and safety in a Phase III trial.

Moderna Files for FDA EUA for mRNA-1273

The added space will house a portion of its PVC, polyurethane, silicone, and additional plastic tubing products, as well as its AdvantaPure products.

NewAge Industries Expands Warehouse Capacity at its Pennsylvania Headquarters

Originally announced in March 2020, the acquired facility will be Bora’s first North American manufacturing facility and will serve as its North American headquarters. 

Bora Pharmaceuticals Completes Acquisition of GSK’s Canadian Facility 

The virtual assessments will address problems, issues, and questions customers have about their environments and operations.

Contec to Provide Virtual Contamination Control Assessments

The expansion is part of a new expansion initiative aimed at increasing flexibility, efficiency, and cost-effective production.

CordenPharma Colorado Completes Peptide Manufacturing Expansion

Behzad Mahdavi, PhD, will join a team of experts in the company’s Science and Technology Group to fast-track the adoption of new development and drug delivery technologies and manufacturing processes and techniques.


Catalent Appoints New Vice President of Open Innovation, Biologics, Cell and Gene Therapy

The companies have entered into a global collaboration and license agreement to develop zuranolone (SAGE-217) for major depressive disorder, postpartum depression (PPD), and SAGE-324 for essential tremor and other neurological disorders.

All News